|
Sudarshan Pharma Industries Ltd.
|
Income Statement
|
|
|
You can view the
Income Statement
for the last 5 years.
|
Market Cap. (Rs.)
|
1006.44 Cr.
|
P/BV
|
6.49
|
Book Value (Rs.)
|
6.44
|
|
52 Week High/Low (Rs.)
|
43/19
|
FV/ML
|
1/4000
|
P/E(X)
|
43.19
|
|
Bookclosure
|
23/11/2024
|
EPS (Rs.)
|
0.97
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
| FaceValue | 1.00 | 1.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| | | | | | |
| INCOME | | | | | |
| Revenue From Operations [Net] | 703.06 | 505.05 | 463.54 | 461.33 | 357.09 |
| Total Operating Revenues | 703.06 | 505.05 | 463.54 | 461.33 | 357.09 |
| | | | | | |
| Other Income | 8.71 | 2.52 | 2.61 | 1.12 | 0.46 |
| Total Revenue | 711.77 | 507.57 | 466.15 | 462.45 | 357.56 |
| | | | | | |
| EXPENSES | | | | | |
| Cost Of Materials Consumed | 39.06 | 8.93 | 6.31 | 0.32 | 360.81 |
| Purchase Of Stock-In Trade | 652.13 | 485.18 | 424.04 | 457.25 | 0.00 |
| Operating And Direct Expenses | 0.00 | 10.32 | 8.79 | 8.13 | 0.00 |
| Changes In Inventories Of FG,WIP And Stock-In Trade | -71.81 | -54.35 | -7.87 | -26.62 | -22.91 |
| Employee Benefit Expenses | 7.44 | 4.89 | 3.64 | 2.98 | 2.43 |
| Finance Costs | 25.70 | 15.77 | 8.94 | 5.40 | 3.38 |
| Depreciation And Amortisation Expenses | 3.79 | 2.22 | 1.24 | 0.91 | 0.87 |
| Other Expenses | 24.93 | 10.16 | 5.82 | 4.59 | 5.79 |
| Total Expenses | 681.23 | 483.12 | 450.92 | 452.95 | 350.37 |
| | | | | | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 30.54 | 24.45 | 15.23 | 9.50 | 7.19 |
| | | | | | |
| Exceptional Items | 0.00 | -2.82 | 0.00 | 0.00 | 0.00 |
| Profit/Loss Before Tax | 30.54 | 21.63 | 15.23 | 9.50 | 7.19 |
| | | | | | |
| Tax Expenses-Continued Operations | | | | | |
| Current Tax | 7.17 | 5.49 | 3.98 | 2.42 | 1.88 |
| Deferred Tax | 0.00 | 0.27 | -0.16 | 0.04 | 0.00 |
| Tax For Earlier Years | 0.00 | -0.08 | -0.05 | 0.00 | 0.00 |
| Total Tax Expenses | 7.17 | 5.68 | 3.77 | 2.46 | 1.89 |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 23.37 | 15.95 | 11.46 | 7.04 | 5.30 |
| | | | | | |
| Profit/Loss From Continuing Operations | 23.37 | 15.95 | 11.46 | 7.04 | 5.30 |
| | | | | | |
| Profit/Loss For The Period | 23.37 | 15.95 | 11.46 | 7.04 | 5.30 |
| | | | | | |
| Minority Interest | -0.07 | 0.00 | 0.00 | 0.00 | 0.00 |
| Consolidated Profit/Loss After MI And Associates | 23.30 | 15.96 | 11.46 | 7.04 | 5.30 |
| | | | | | |
| OTHER INFORMATION | | | | | |
| | | | | | |
| EARNINGS PER SHARE | | | | | |
| Basic EPS (Rs.) | 0.97 | 0.66 | 4.76 | 5.48 | 5.52 |
| Diluted EPS (Rs.) | 0.97 | 0.66 | 4.76 | 5.48 | 5.52 |
| | | | | | |
| DIVIDEND AND DIVIDEND PERCENTAGE | | | | | |
| Equity Share Dividend | 0.00 | 0.00 | 0.72 | 0.00 | 0.00 |
